Home/Filings/4/0001209191-23-039508
4//SEC Filing

Rochlin Kate 4

Accession 0001209191-23-039508

CIK 0001740279other

Filed

Jun 22, 8:00 PM ET

Accepted

Jun 23, 6:27 PM ET

Size

5.7 KB

Accession

0001209191-23-039508

Insider Transaction Report

Form 4
Period: 2023-06-21
Rochlin Kate
Chief Operating Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2023-06-21+67,80067,800 total
    Exercise: $2.01Exp: 2033-06-21Common Stock (67,800 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the shares subject to the option shall vest on June 21, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

Issuer

IN8BIO, INC.

CIK 0001740279

Entity typeother

Related Parties

1
  • filerCIK 0001898521

Filing Metadata

Form type
4
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 6:27 PM ET
Size
5.7 KB